United States Alpha1-Proteinase Inhibitor Market Report 2018

March 2018 | 95 pages | ID: UF2F99B800DEN
QYResearch

Abstracts

In this report, the United States Alpha1-Proteinase Inhibitor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Alpha1-Proteinase Inhibitor in these regions, from 2013 to 2025 (forecast).

United States Alpha1-Proteinase Inhibitor market competition by top manufacturers/players, with Alpha1-Proteinase Inhibitor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• Kamada
• Talecris Biotherapeutics
• Aventis Behring

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 0.5g
• 1g

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Alpha1-Proteinase Inhibitor Market Report 2018

1 ALPHA1-PROTEINASE INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Alpha1-Proteinase Inhibitor
1.2 Classification of Alpha1-Proteinase Inhibitor by Product Category
  1.2.1 United States Alpha1-Proteinase Inhibitor Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Alpha1-Proteinase Inhibitor Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 0.5g
  1.2.4 1g
1.3 United States Alpha1-Proteinase Inhibitor Market by Application/End Users
  1.3.1 United States Alpha1-Proteinase Inhibitor Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 United States Alpha1-Proteinase Inhibitor Market by Region
  1.4.1 United States Alpha1-Proteinase Inhibitor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
  1.4.3 Southwest Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
  1.4.5 New England Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
  1.4.6 The South Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
  1.4.7 The Midwest Alpha1-Proteinase Inhibitor Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Alpha1-Proteinase Inhibitor (2013-2025)
  1.5.1 United States Alpha1-Proteinase Inhibitor Sales and Growth Rate (2013-2025)
  1.5.2 United States Alpha1-Proteinase Inhibitor Revenue and Growth Rate (2013-2025)

2 UNITED STATES ALPHA1-PROTEINASE INHIBITOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Alpha1-Proteinase Inhibitor Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Alpha1-Proteinase Inhibitor Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Alpha1-Proteinase Inhibitor Average Price by Players/Suppliers (2013-2018)
2.4 United States Alpha1-Proteinase Inhibitor Market Competitive Situation and Trends
  2.4.1 United States Alpha1-Proteinase Inhibitor Market Concentration Rate
  2.4.2 United States Alpha1-Proteinase Inhibitor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alpha1-Proteinase Inhibitor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALPHA1-PROTEINASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Alpha1-Proteinase Inhibitor Sales and Market Share by Region (2013-2018)
3.2 United States Alpha1-Proteinase Inhibitor Revenue and Market Share by Region (2013-2018)
3.3 United States Alpha1-Proteinase Inhibitor Price by Region (2013-2018)

4 UNITED STATES ALPHA1-PROTEINASE INHIBITOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Alpha1-Proteinase Inhibitor Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Alpha1-Proteinase Inhibitor Revenue and Market Share by Type (2013-2018)
4.3 United States Alpha1-Proteinase Inhibitor Price by Type (2013-2018)
4.4 United States Alpha1-Proteinase Inhibitor Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ALPHA1-PROTEINASE INHIBITOR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Alpha1-Proteinase Inhibitor Sales and Market Share by Application (2013-2018)
5.2 United States Alpha1-Proteinase Inhibitor Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALPHA1-PROTEINASE INHIBITOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alpha1-Proteinase Inhibitor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Alpha1-Proteinase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Kamada
  6.2.2 Alpha1-Proteinase Inhibitor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Kamada Alpha1-Proteinase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Talecris Biotherapeutics
  6.3.2 Alpha1-Proteinase Inhibitor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Aventis Behring
  6.4.2 Alpha1-Proteinase Inhibitor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Aventis Behring Alpha1-Proteinase Inhibitor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 ALPHA1-PROTEINASE INHIBITOR MANUFACTURING COST ANALYSIS

7.1 Alpha1-Proteinase Inhibitor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alpha1-Proteinase Inhibitor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alpha1-Proteinase Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alpha1-Proteinase Inhibitor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALPHA1-PROTEINASE INHIBITOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Alpha1-Proteinase Inhibitor Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Alpha1-Proteinase Inhibitor Sales Volume Forecast by Type (2018-2025)
11.3 United States Alpha1-Proteinase Inhibitor Sales Volume Forecast by Application (2018-2025)
11.4 United States Alpha1-Proteinase Inhibitor Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Alpha1-Proteinase Inhibitor
Figure United States Alpha1-Proteinase Inhibitor Market Size (K Units) by Type (2013-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume Market Share by Type (Product Category) in 2017
Figure 0.5g Product Picture
Figure 1g Product Picture
Figure United States Alpha1-Proteinase Inhibitor Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Alpha1-Proteinase Inhibitor by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States Alpha1-Proteinase Inhibitor Market Size (Million USD) by Region (2013-2025)
Figure The West Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales (K Units) and Growth Rate (2013-2025)
Figure United States Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Alpha1-Proteinase Inhibitor Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Alpha1-Proteinase Inhibitor Sales Share by Players/Suppliers
Figure 2017 United States Alpha1-Proteinase Inhibitor Sales Share by Players/Suppliers
Figure United States Alpha1-Proteinase Inhibitor Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Alpha1-Proteinase Inhibitor Revenue Share by Players/Suppliers
Figure 2017 United States Alpha1-Proteinase Inhibitor Revenue Share by Players/Suppliers
Table United States Market Alpha1-Proteinase Inhibitor Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Alpha1-Proteinase Inhibitor Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Alpha1-Proteinase Inhibitor Market Share of Top 3 Players/Suppliers
Figure United States Alpha1-Proteinase Inhibitor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alpha1-Proteinase Inhibitor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alpha1-Proteinase Inhibitor Product Category
Table United States Alpha1-Proteinase Inhibitor Sales (K Units) by Region (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales Share by Region (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Share by Region (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Market Share by Region in 2017
Table United States Alpha1-Proteinase Inhibitor Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Revenue Share by Region (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Revenue Market Share by Region in 2017
Table United States Alpha1-Proteinase Inhibitor Price (USD/Unit) by Region (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales (K Units) by Type (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales Share by Type (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Share by Type (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Market Share by Type in 2017
Table United States Alpha1-Proteinase Inhibitor Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Alpha1-Proteinase Inhibitor by Type (2013-2018)
Figure Revenue Market Share of Alpha1-Proteinase Inhibitor by Type in 2017
Table United States Alpha1-Proteinase Inhibitor Price (USD/Unit) by Types (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Growth Rate by Type (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales (K Units) by Application (2013-2018)
Table United States Alpha1-Proteinase Inhibitor Sales Market Share by Application (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Market Share by Application (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Market Share by Application in 2017
Table United States Alpha1-Proteinase Inhibitor Sales Growth Rate by Application (2013-2018)
Figure United States Alpha1-Proteinase Inhibitor Sales Growth Rate by Application (2013-2018)
Table Baxter Basic Information List
Table Baxter Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Alpha1-Proteinase Inhibitor Sales Growth Rate (2013-2018)
Figure Baxter Alpha1-Proteinase Inhibitor Sales Market Share in United States (2013-2018)
Figure Baxter Alpha1-Proteinase Inhibitor Revenue Market Share in United States (2013-2018)
Table Kamada Basic Information List
Table Kamada Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kamada Alpha1-Proteinase Inhibitor Sales Growth Rate (2013-2018)
Figure Kamada Alpha1-Proteinase Inhibitor Sales Market Share in United States (2013-2018)
Figure Kamada Alpha1-Proteinase Inhibitor Revenue Market Share in United States (2013-2018)
Table Talecris Biotherapeutics Basic Information List
Table Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales Growth Rate (2013-2018)
Figure Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Sales Market Share in United States (2013-2018)
Figure Talecris Biotherapeutics Alpha1-Proteinase Inhibitor Revenue Market Share in United States (2013-2018)
Table Aventis Behring Basic Information List
Table Aventis Behring Alpha1-Proteinase Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aventis Behring Alpha1-Proteinase Inhibitor Sales Growth Rate (2013-2018)
Figure Aventis Behring Alpha1-Proteinase Inhibitor Sales Market Share in United States (2013-2018)
Figure Aventis Behring Alpha1-Proteinase Inhibitor Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha1-Proteinase Inhibitor
Figure Manufacturing Process Analysis of Alpha1-Proteinase Inhibitor
Figure Alpha1-Proteinase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Alpha1-Proteinase Inhibitor Major Players/Suppliers in 2017
Table Major Buyers of Alpha1-Proteinase Inhibitor
Table Distributors/Traders List
Figure United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Type in 2025
Table United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Application in 2025
Table United States Alpha1-Proteinase Inhibitor Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Alpha1-Proteinase Inhibitor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Alpha1-Proteinase Inhibitor Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources